A shocking new study reveals that a condition that can lead to limb amputation is far more prevalent and deadly than ...

A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million ...

Treatment with semaglutide improved maximum walking distance in patients with type 2 diabetes (T2D) and symptomatic peripheral artery disease (PAD), according to results from the STRIDE trial ...

A new drug in clinical trials is showing promise in lowering a key genetic risk factor for heart attacks and ...

The GLP-1 agonist has shown convincing benefits in yet another population, patients with peripheral arterial disease, in a ...

In an article published online in Journal of Vascular Surgery evaluating radiation dose exposure for vascular surgery ...

The treatment of many patients with peripheral artery disease is not optimal, and indeed is much worse than that in patients ...

Semaglutide associated with increased walking distance in patients with symptomatic peripheral artery disease and type 2 diabetes.

Shockwave Medical has commenced the IDE study of the Javelin Coronary IVL Catheter for treating calcified coronary lesions.